JANE STREET GROUP, LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$236,662

+$90,798 QoQ

Shares Held

241,493

+67.2% QoQ

Ownership

0.356%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 60 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. TCRX ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$236,662	241,493	+67.2%	Shares	Defined	2026-08-14
2026-03-31	$145,864	144,421	-62.8%	Shares	Defined	2026-05-12
2025-12-31	$388,284	388,284	+377.5%	Shares	Defined	2026-02-12
2025-09-30	$147,995	81,316	-61.9%	Shares	Defined	2025-11-14
2025-06-30	$309,423	213,396	+127.3%	Shares	Defined	2025-08-14
2024-09-30	$467,502	93,876	-5.2%	Shares	Defined	2024-11-15
2024-06-30	$579,360	99,036	-35.3%	Shares	Defined	2024-08-15
2024-03-31	$1,215,875	153,133	+83.1%	Shares	Defined	2024-05-16
2023-12-31	$487,516	83,622	+721.8%	Shares	Defined	2024-02-15
2022-06-30	$32,003	10,176	-10.0%	Shares	Defined	2022-08-16
2021-12-31	$50,881	11,307	—	Shares	Defined	2022-02-15
No filing history on record for this holder in this stock.